“It's not the tools that you have faith in: tools are just tools. They work, or they don't work. It's people you have faith in or not.”Steve Jobs
“It's not the tools that you have faith in: tools are just tools. They work, or they don't work. It's people you have faith in or not.”
Three decades ago, the schizophrenia field finally began to challenge the intrinsic pessimism that had inhibited preventive approaches for a century. Early detection and specialized early treatment models for first-episode psychosis have since become the global standard of care, producing better outcomes that “bend the curve” of the early course of illness1 and have opened the door to the prevention or delay of the first episode of psychosis. The development of operational criteria (the “ultra” or “clinical” high risk [CHR] criteria) for identifying what we originally termed the at-risk mental state meant that an even earlier stage of illness could be identified prospectively and studied for its heuristic and therapeutic potential.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
McGorry PD, Nelson B. Clinical High Risk for Psychosis—Not Seeing the Trees for the Wood. JAMA Psychiatry. 2020;77(7):559–560. doi:10.1001/jamapsychiatry.2019.4635
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: